Breast cancer treatment
31 – 40 of 238
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750)
Skarping, Ida LU
; Ellbrant, Julia
LU
; Dihge, Looket
LU
; Ohlsson, Mattias
LU
; Huss, Linnea
LU
; Bendahl, Pär Ola
LU
and Rydén, Lisa
LU
(2024)
In BMC Cancer
24(1).
- Contribution to journal › Article
-
Mark
G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer cells
Tutzauer, Julia LU
; Serafin, D. Stephen
; Schmidt, Tobias
LU
; Olde, Björn
LU
; Caron, Kathleen M.
and Leeb-Lundberg, L. M.Fredrik
LU
(2024)
In Archives of Biochemistry and Biophysics
752.
- Contribution to journal › Article
-
Mark
Clinical cell-surface targets in metastatic and primary solid cancers
- Contribution to journal › Article
- 2023
-
Mark
Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer : A Swedish retrospective cohort study
Thurell, Jacob ; Manouchehri, Narges ; Fredriksson, Irma ; Wilking, Ulla ; Bergh, Jonas ; Ryden, Lisa LU
; Koppert, Linetta B.
; Karsten, Maria M.
; Kiani, Narsis A.
and Hedayati, Elham
(2023)
In Breast
70.
p.18-24
- Contribution to journal › Article
-
Mark
Risk factors for seroma formation after axillary lymph node dissection with special focus on the impact of early shoulder exercise
- Contribution to journal › Article
-
Mark
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy : A systematic review and meta-analysis
- Contribution to journal › Scientific review
-
Mark
Reply to V. Nardone et al
- Contribution to journal › Debate/Note/Editorial
-
Mark
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
Nordenskjöld, Anna ; Fohlin, Helena ; Rosell, Johan ; Bengtsson, Nils Olof ; Fornander, Tommy ; Hatschek, Thomas ; Lindman, Henrik ; Malmström, Per LU ; Rydén, Lisa LU
and Wallgren, Arne
, et al.
(2023)
In Breast
71.
p.63-68
- Contribution to journal › Article
-
Mark
Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer : A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin
- Contribution to journal › Article
-
Mark
Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells
- Contribution to journal › Article